Skip to main content

Table 2 Univariate and multivariate analysis of factors affecting baseline HE and visual acuity

From: Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema

 

Baseline BCVAa

Baseline HE areab

Variable

Beta

P value

Beta

P value

 
  

Univariable

 

Univariable

Multivariable

Male

3.098

0.631

0.915

0.127

 

Presence of SRF

-4.8

0.476

0.169

0.773

 

Diffuse type ME

-6.09

0.319

-0.077

0.708

 

Age

-0.33

0.288

0.009

0.708

 

HbA1c

-4.191

0.02*

-0.077

0.746

 

BUN

-0.755

0.203

0.007

0.874

 

Cr

3.856

0.445

0.284

0.209

 

TG

0.011

0.794

0.003

0.19

 

Total cholesterol

0.006

0.918

0.009

0.001*

0.165

HDL

-0.018

0.933

0

0.991

 

LDL

0.077

0.506

0.008

0.013*

0.72

Microaneurysm count

-0.353

0.116

0.036

< 0.001*

< 0.001*

HE area

-0.171

0.908

   

HE1500 area

-6.839

0.316

   

CMT

-0.025

0.258

0.002

0.189

 
  1. BCVA best corrected visual acuity, Presence of SRF presence of macular subretinal fluid, DME diabetic macular edema, BUN blood urea nitrogen, Cr creatinine, TG triglyceride, HDL high density lipoprotein, LDL low density lipoprotein, HE hard exudate, HE1500 HE within 1500 μm from the fovea, CMT central macular thickness
  2. *P value less than 0.05; alinear regression analysis; blinear regression analysis after log transformation of HE area